RxDoctor Payments DataLook up a doctor →

Steven Sacket, MD

Family Medicine · Oklahoma City, OKNPI 1538196886

Payments from drug & device makers

$17,488in general payments, 2019–2025

Across 1,135 payments — averaging $15.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Pfizer$2K
  • AbbVie$1K
  • Amgen$1K
  • GSK$1K
  • plus $9K from 51 others

What the payments were for

  • Food & beverage$17,24099%
  • Education$2491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca39$1,620
Novo Nordisk133$1,574
Pfizer118$1,535
AbbVie(2 entities)126$1,309
Amgen(2 entities)58$1,271
GSK85$1,015
Abbott46$814
Astellas Pharma US Inc43$813
Lilly USA, LLC61$777
Amarin Pharma, Inc.49$726
Boehringer Ingelheim42$668
Bayer39$569
Merck49$486
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC27$422
Takeda Pharmaceuticals U.S.A., Inc.22$355
Corium, LLC14$288
Axsome Therapeutics, Inc.10$278
Esperion Therapeutics, Inc.12$275
Johnson & Johnson17$234
Biohaven Pharmaceutical Holding Company Ltd.6$191
Idorsia Pharmaceuticals US Inc9$159
Shire North American Group Inc10$155
Genentech USA, Inc.9$142
Ironwood Pharmaceuticals, Inc9$129
Sumitomo Pharma America, Inc.6$116
Sanofi-aventis U.S. LLC8$110
Adlon Therapeutics L.p.6$95
Supernus Pharmaceuticals, Inc.2$88
Antares Pharma, Inc.6$87
Novartis6$86
Exact Sciences5$82
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$79
Ironshore Pharmaceuticals Inc.4$77
Biohaven Pharmaceuticals, Inc.4$70
Kowa Pharmaceuticals America, Inc.5$66
Eisai Inc.4$66
Radius Health, Inc.2$62
Upsher-smith Laboratories LLC3$61
Jazz Pharmaceuticals Inc.4$61
Phathom Pharmaceuticals, Inc.5$45
Sanofi Pasteur Inc.2$37
Aytu Biopharma, Inc.3$36
Ardelyx, Inc.2$34
Halozyme Inc2$29
IBSA Pharma Inc.2$28
Scilex Pharmaceuticals Inc.2$27
Dexcom, Inc.2$26
Almatica Pharma LLC2$26
Dynavax Technologies Corporation2$25
Xeris Pharmaceuticals, Inc.1$24
Medtronic1$23
Alnylam Pharmaceuticals Inc.2$23
Inspire Medical Systems, Inc.1$22
Lundbeck LLC1$22
Sunovion Pharmaceuticals Inc.1$20
Tris Pharma Inc1$19
Nalpropion Pharmaceuticals LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,488 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$123,719
Medicare patients
364
Services billed
2,419

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin58$69,372
EliquisApixaban69$68,338
FarxigaDapagliflozin Propanediol52$55,401
OzempicSemaglutide36$54,298
MyrbetriqMirabegron29$25,970
MounjaroTirzepatide24$24,919
TrulicityDulaglutide19$23,673
XareltoRivaroxaban25$21,666
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$20,770
VraylarCariprazine Hcl11$18,522
Atorvastatin Calcium427$6,563
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen167$3,865
Levothyroxine Sodium333$3,707
Gabapentin178$3,517
Losartan Potassium228$3,070

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$668$69,37258 claims
PfizerEliquis$1,535$68,33869 claims
AstraZenecaFarxiga$1,620$55,40152 claims
Novo NordiskOzempic$1,574$54,29836 claims
Lilly USA, LLCMounjaro, Trulicity$777$48,59243 claims
Astellas Pharma US IncMyrbetriq$813$25,97029 claims
Johnson & JohnsonXarelto$234$21,66625 claims
GSKTrelegy Ellipta$1,015$20,77018 claims
AbbVieVraylar, Synthroid$1,309$20,16335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →